Omar Abdel-Wahab is an Assistant Member in the Human Oncology and Pathogenesis Program (HOPP) and an Attending Physician on the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center. Dr. Abdel-Wahab’s research focuses on the role of disordered epigenetic modifiers in the pathogenesis of hematopoietic malignancies.
Omar I. Abdel-Wahab, MD
Assistant Professor
Research Focus
Physician-scientist Omar Abdel-Wahab studies the functional genomics of hematopoietic malignancies.Education
MD, Duke University School of Medicine
Publications
- 1: Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, Li Y, Chung YR, Micol JB, Murphy ME, Cho H, Kim MK, Zebari AS, Aumann S, Park CY, Buonamici S, Smith PG, Deeg HJ, Lobry C, Aifantis I, Modis Y, Allain FH, Halene S, Bradley RK, Abdel-Wahab O. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition. Cancer Cell. 2015 May 11;27(5):617-630. doi: 10.1016/j.ccell.2015.04.006.
- 2: Meldi K, Qin T, Buchi F, Droin N, Sotzen J, Micol JB, Selimoglu-Buet D, Masala E, Allione B, Gioia D, Poloni A, Lunghi M, Solary E, Abdel-Wahab O, Santini V, Figueroa ME. Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia. J Clin Invest. 2015 May 1;125(5):1857-72. doi: 10.1172/JCI78752. Epub 2015 Mar 30.
Selected Achievements
- Boyer Clinical Investigator Award
- American Society of Clinical Investigation, Early Investigator Award
- V Foundation Scholar Award
- Damon Runyon Clinical Investigator Award
- American Society of Hematology Junior Faculty Award
Read more
- Josie Robertson Young Investigator Award, Robertson Foundation (2012)
- Fellow Scholar Award, Gabrielle’s Angel Foundation (2011)
